RecruitingNCT07367880

The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)


Sponsor

University Hospital, Grenoble

Enrollment

220 participants

Start Date

Feb 23, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.


Eligibility

Min Age: 50 YearsMax Age: 95 Years

Inclusion Criteria8

  • Alzheimer's disease:
  • Age ≥ 50 years and older
  • Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011.
  • Score 18≤ MMSE ≤26
  • Controls:
  • Age ≥ 50 years and older
  • MMSE score ≥ 26 For all subjects
  • No objection from the participant

Exclusion Criteria10

  • Alzheimer's disease:
  • Persons referred to in Articles L1121-5 to L1121-8 of the CSP
  • Controls:
  • Memory complaints
  • Persons referred to in Articles L1121-5 to L1121-8 of the CSP For all subjects
  • Significant neurological or psychiatric history
  • Taking psychotropic medication (neuroleptics)
  • Poor command of the French language, comprehension difficulties
  • Significant hearing or visual impairments (diplopia, nystagmus, scotoma, etc.)
  • Insufficient exposure to the media and/or socio-cultural knowledge (questionnaire) ; Deficit in face recognition (Benton Face Recognition Test)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERIdentification and naming task

Task of identification and naming of landmarks and celebrities


Locations(1)

CHU Grenoble Alpes

Grenoble, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07367880


Related Trials